Mounjaro Price Set to Skyrocket by 170% in UK from 2025
Brace yourselves, Mounjaro users! The cost of Eli Lilly’s popular weight-loss drug is set to soar in the UK from 1 September 2025. Some dosages could become a staggering 170% more expensive, hitting thousands of patients hard.
Why the Massive Price Hike?
Eli Lilly explains the steep increase aims to fix “pricing inconsistencies” between the UK and other developed nations. The pharma giant insists this move will ensure fair contributions from all markets towards funding medical research.
All Dosages Affected Across the Board
The new price tags will apply to every dosage strength of Mounjaro (generic name: tirzepatide) and impact every regulated supplier in the UK. Eli Lilly stresses this isn’t just one company’s move but part of an industry-wide price realignment.
Mounjaro Demand Booms, Costs Hit Patients
Since gaining approval for weight management alongside type 2 diabetes treatment, Mounjaro has been flying off the shelves. However, the looming price hike threatens thousands who currently self-fund prescriptions via private providers, making the drug less affordable for many.
